NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Another reason for not buying is possible long term partnership talks tied into milestones. One thing is for certain and that is NWBO needs the SP much higher once approval is made as a ton of money would be needed to move this project into the next phase. I am still banking on partnership announcements relating to combos etc that will prompt uplisting and much more available cash to expand manufacturing etc and start multiple trials concurrently. There is no way that NWBO has the financial ability at this share price to pull off massive interest in DCVAX-L for both GBM and off label use once the market is awakened. The full Nature article on the combo trial may be the kick start of this whole operation that moves us away from the control of the natsayers.